Global and United States Melanoma Therapeutics Market Report & Forecast 2023-2028

Report ID: 1835133 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Melanoma Therapeutics Revenue in Melanoma Therapeutics Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Melanoma Therapeutics Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Melanoma Therapeutics Market Size for the Year 2017-2028
        1.2.2 Global Melanoma Therapeutics Market Size for the Year 2017-2028
    1.3 Melanoma Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Melanoma Therapeutics in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Melanoma Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Melanoma Therapeutics Market Dynamics
        1.4.1 Melanoma Therapeutics Industry Trends
        1.4.2 Melanoma Therapeutics Market Drivers
        1.4.3 Melanoma Therapeutics Market Challenges
        1.4.4 Melanoma Therapeutics Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Melanoma Therapeutics by Type
    2.1 Melanoma Therapeutics Market Segment by Type
        2.1.1 Chemotherapy
        2.1.2 Immunotherapy
        2.1.3 Targeted Therapy
        2.1.4 Radiation Therapy
        2.1.5 Others
    2.2 Global Melanoma Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.3 Global Melanoma Therapeutics Market Size by Type (2017-2028)
    2.4 United States Melanoma Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.5 United States Melanoma Therapeutics Market Size by Type (2017-2028)
3 Melanoma Therapeutics by Application
    3.1 Melanoma Therapeutics Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Others
    3.2 Global Melanoma Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.3 Global Melanoma Therapeutics Market Size by Application (2017-2028)
    3.4 United States Melanoma Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.5 United States Melanoma Therapeutics Market Size by Application (2017-2028)
4 Global Melanoma Therapeutics Competitor Landscape by Company
    4.1 Global Melanoma Therapeutics Market Size by Company
        4.1.1 Top Global Melanoma Therapeutics Companies Ranked by Revenue (2021)
        4.1.2 Global Melanoma Therapeutics Revenue by Player (2017-2022)
    4.2 Global Melanoma Therapeutics Concentration Ratio (CR)
        4.2.1 Melanoma Therapeutics Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Melanoma Therapeutics in 2021
        4.2.3 Global Melanoma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Melanoma Therapeutics Headquarters, Revenue in Melanoma Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Melanoma Therapeutics Headquarters and Area Served
        4.3.2 Global Melanoma Therapeutics Companies Revenue in Melanoma Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Melanoma Therapeutics Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Melanoma Therapeutics Market Size by Company
        4.5.1 Top Melanoma Therapeutics Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Melanoma Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Melanoma Therapeutics Market Size by Region
    5.1 Global Melanoma Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Melanoma Therapeutics Market Size by Region (2017-2028)
        5.2.1 Global Melanoma Therapeutics Market Size by Region: 2017-2022
        5.2.2 Global Melanoma Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Melanoma Therapeutics Market Size YoY Growth 2017-2028
        6.1.2 North America Melanoma Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Melanoma Therapeutics Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Melanoma Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Melanoma Therapeutics Market Size YoY Growth 2017-2028
        6.3.2 Europe Melanoma Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Melanoma Therapeutics Market Size YoY Growth 2017-2028
        6.4.2 Latin America Melanoma Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Melanoma Therapeutics Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Melanoma Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 AstraZeneca
        7.1.1 AstraZeneca Company Details
        7.1.2 AstraZeneca Business Overview
        7.1.3 AstraZeneca Melanoma Therapeutics Introduction
        7.1.4 AstraZeneca Revenue in Melanoma Therapeutics Business (2017-2022)
        7.1.5 AstraZeneca Recent Development
    7.2 Amgen, Inc.
        7.2.1 Amgen, Inc. Company Details
        7.2.2 Amgen, Inc. Business Overview
        7.2.3 Amgen, Inc. Melanoma Therapeutics Introduction
        7.2.4 Amgen, Inc. Revenue in Melanoma Therapeutics Business (2017-2022)
        7.2.5 Amgen, Inc. Recent Development
    7.3 Roche.
        7.3.1 Roche. Company Details
        7.3.2 Roche. Business Overview
        7.3.3 Roche. Melanoma Therapeutics Introduction
        7.3.4 Roche. Revenue in Melanoma Therapeutics Business (2017-2022)
        7.3.5 Roche. Recent Development
    7.4 Bristol-Myers Squibb Company
        7.4.1 Bristol-Myers Squibb Company Company Details
        7.4.2 Bristol-Myers Squibb Company Business Overview
        7.4.3 Bristol-Myers Squibb Company Melanoma Therapeutics Introduction
        7.4.4 Bristol-Myers Squibb Company Revenue in Melanoma Therapeutics Business (2017-2022)
        7.4.5 Bristol-Myers Squibb Company Recent Development
    7.5 Novartis AG
        7.5.1 Novartis AG Company Details
        7.5.2 Novartis AG Business Overview
        7.5.3 Novartis AG Melanoma Therapeutics Introduction
        7.5.4 Novartis AG Revenue in Melanoma Therapeutics Business (2017-2022)
        7.5.5 Novartis AG Recent Development
    7.6 Merck & Co., Inc.
        7.6.1 Merck & Co., Inc. Company Details
        7.6.2 Merck & Co., Inc. Business Overview
        7.6.3 Merck & Co., Inc. Melanoma Therapeutics Introduction
        7.6.4 Merck & Co., Inc. Revenue in Melanoma Therapeutics Business (2017-2022)
        7.6.5 Merck & Co., Inc. Recent Development
    7.7 Daiichi Sankyo Company, Limited
        7.7.1 Daiichi Sankyo Company, Limited Company Details
        7.7.2 Daiichi Sankyo Company, Limited Business Overview
        7.7.3 Daiichi Sankyo Company, Limited Melanoma Therapeutics Introduction
        7.7.4 Daiichi Sankyo Company, Limited Revenue in Melanoma Therapeutics Business (2017-2022)
        7.7.5 Daiichi Sankyo Company, Limited Recent Development
    7.8 AB Sciences
        7.8.1 AB Sciences Company Details
        7.8.2 AB Sciences Business Overview
        7.8.3 AB Sciences Melanoma Therapeutics Introduction
        7.8.4 AB Sciences Revenue in Melanoma Therapeutics Business (2017-2022)
        7.8.5 AB Sciences Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Melanoma Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Melanoma Therapeutics Market Trends
    Table 3. Melanoma Therapeutics Market Drivers
    Table 4. Melanoma Therapeutics Market Challenges
    Table 5. Melanoma Therapeutics Market Restraints
    Table 6. Global Melanoma Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Melanoma Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Melanoma Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Melanoma Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Melanoma Therapeutics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Melanoma Therapeutics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Melanoma Therapeutics Revenue Share by Player, 2017-2022
    Table 13. Global Melanoma Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Melanoma Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Therapeutics as of 2021)
    Table 15. Top Players of Melanoma Therapeutics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Melanoma Therapeutics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Melanoma Therapeutics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Melanoma Therapeutics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Melanoma Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Melanoma Therapeutics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Melanoma Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Melanoma Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Melanoma Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Melanoma Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Melanoma Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Melanoma Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Melanoma Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Melanoma Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. AstraZeneca Company Details
    Table 31. AstraZeneca Business Overview
    Table 32. AstraZeneca Melanoma Therapeutics Product
    Table 33. AstraZeneca Revenue in Melanoma Therapeutics Business (2017-2022) & (US$ Million)
    Table 34. AstraZeneca Recent Development
    Table 35. Amgen, Inc. Company Details
    Table 36. Amgen, Inc. Business Overview
    Table 37. Amgen, Inc. Melanoma Therapeutics Product
    Table 38. Amgen, Inc. Revenue in Melanoma Therapeutics Business (2017-2022) & (US$ Million)
    Table 39. Amgen, Inc. Recent Development
    Table 40. Roche. Company Details
    Table 41. Roche. Business Overview
    Table 42. Roche. Melanoma Therapeutics Product
    Table 43. Roche. Revenue in Melanoma Therapeutics Business (2017-2022) & (US$ Million)
    Table 44. Roche. Recent Development
    Table 45. Bristol-Myers Squibb Company Company Details
    Table 46. Bristol-Myers Squibb Company Business Overview
    Table 47. Bristol-Myers Squibb Company Melanoma Therapeutics Product
    Table 48. Bristol-Myers Squibb Company Revenue in Melanoma Therapeutics Business (2017-2022) & (US$ Million)
    Table 49. Bristol-Myers Squibb Company Recent Development
    Table 50. Novartis AG Company Details
    Table 51. Novartis AG Business Overview
    Table 52. Novartis AG Melanoma Therapeutics Product
    Table 53. Novartis AG Revenue in Melanoma Therapeutics Business (2017-2022) & (US$ Million)
    Table 54. Novartis AG Recent Development
    Table 55. Merck & Co., Inc. Company Details
    Table 56. Merck & Co., Inc. Business Overview
    Table 57. Merck & Co., Inc. Melanoma Therapeutics Product
    Table 58. Merck & Co., Inc. Revenue in Melanoma Therapeutics Business (2017-2022) & (US$ Million)
    Table 59. Merck & Co., Inc. Recent Development
    Table 60. Daiichi Sankyo Company, Limited Company Details
    Table 61. Daiichi Sankyo Company, Limited Business Overview
    Table 62. Daiichi Sankyo Company, Limited Melanoma Therapeutics Product
    Table 63. Daiichi Sankyo Company, Limited Revenue in Melanoma Therapeutics Business (2017-2022) & (US$ Million)
    Table 64. Daiichi Sankyo Company, Limited Recent Development
    Table 65. AB Sciences Company Details
    Table 66. AB Sciences Business Overview
    Table 67. AB Sciences Melanoma Therapeutics Product
    Table 68. AB Sciences Revenue in Melanoma Therapeutics Business (2017-2022) & (US$ Million)
    Table 69. AB Sciences Recent Development
    Table 70. Research Programs/Design for This Report
    Table 71. Key Data Information from Secondary Sources
    Table 72. Key Data Information from Primary Sources
List of Figures
    Figure 1. Melanoma Therapeutics Product Picture
    Figure 2. Global Melanoma Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Melanoma Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Melanoma Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Melanoma Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Melanoma Therapeutics Market Share in Global 2017-2028
    Figure 7. Melanoma Therapeutics Report Years Considered
    Figure 8. Product Picture of Chemotherapy
    Figure 9. Product Picture of Immunotherapy
    Figure 10. Product Picture of Targeted Therapy
    Figure 11. Product Picture of Radiation Therapy
    Figure 12. Product Picture of Others
    Figure 13. Global Melanoma Therapeutics Market Share by Type in 2022 & 2028
    Figure 14. Global Melanoma Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. Global Melanoma Therapeutics Market Share by Type (2017-2028)
    Figure 16. United States Melanoma Therapeutics Market Share by Type in 2022 & 2028
    Figure 17. United States Melanoma Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 18. United States Melanoma Therapeutics Market Share by Type (2017-2028)
    Figure 19. Product Picture of Hospitals
    Figure 20. Product Picture of Clinics
    Figure 21. Product Picture of Others
    Figure 22. Global Melanoma Therapeutics Market Share by Application in 2022 & 2028
    Figure 23. Global Melanoma Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. Global Melanoma Therapeutics Market Share by Application (2017-2028)
    Figure 25. United States Melanoma Therapeutics Market Share by Application in 2022 & 2028
    Figure 26. United States Melanoma Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. United States Melanoma Therapeutics Market Share by Application (2017-2028)
    Figure 28. North America Melanoma Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. U.S. Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Canada Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Europe Melanoma Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. Germany Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. France Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. U.K. Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Italy Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Russia Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Melanoma Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. China Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Japan Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. South Korea Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. India Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Australia Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Taiwan Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Indonesia Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Thailand Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Malaysia Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Philippines Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Latin America Melanoma Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Mexico Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Brazil Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Argentina Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Melanoma Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Turkey Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. U.A.E Melanoma Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. AstraZeneca Revenue Growth Rate in Melanoma Therapeutics Business (2017-2022)
    Figure 57. Amgen, Inc. Revenue Growth Rate in Melanoma Therapeutics Business (2017-2022)
    Figure 58. Roche. Revenue Growth Rate in Melanoma Therapeutics Business (2017-2022)
    Figure 59. Bristol-Myers Squibb Company Revenue Growth Rate in Melanoma Therapeutics Business (2017-2022)
    Figure 60. Novartis AG Revenue Growth Rate in Melanoma Therapeutics Business (2017-2022)
    Figure 61. Merck & Co., Inc. Revenue Growth Rate in Melanoma Therapeutics Business (2017-2022)
    Figure 62. Daiichi Sankyo Company, Limited Revenue Growth Rate in Melanoma Therapeutics Business (2017-2022)
    Figure 63. AB Sciences Revenue Growth Rate in Melanoma Therapeutics Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
Amgen, Inc.
Roche.
Bristol-Myers Squibb Company
Novartis AG
Merck & Co., Inc.
Daiichi Sankyo Company, Limited
AB Sciences
Frequently Asked Questions
Melanoma Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Melanoma Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Melanoma Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Thalassemia

Thalassemia market is segmented by region (country), players, by Type and by Application. Players ... Read More